MedTrace Logo

Effect of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control

NCT07705191 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-15

No results posted yet for this study

Summary

The objective of this study is to investigate the effects of pre-meal supplementation with SugarLock® peanut skin extract and white kidney bean extract on reducing or delaying postprandial blood glucose elevation and glycemic fluctuations, and to evaluate their potential as nutritional supplements for postprandial glycemic management.

Conditions

  • Blood Sugar (Glucose) Control
  • Postprandial Glucose

Interventions

DIETARY_SUPPLEMENT

White kidney bean extract

consume two White kidney bean extract capsules (250 mg/capsule) with 150 mL water

DIETARY_SUPPLEMENT

Peanut skin extract

consume two peanut skin extract capsules (200 mg/capsule) with 150 mL water

DIETARY_SUPPLEMENT

Water

consume 150 mL water

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Fang-Pei Chen · Chang Jung Christian University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-09
Primary Completion
2026-09-30
Completion
2026-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07705191 on ClinicalTrials.gov